PD-L1/PD-1 interaction in the tumor microenvironment (TME) also promotes T cell dysfunction, exhaustion, apoptosis, neutralization, and production of Interleukin (IL)-10 creating a state of resistance from Cytotoxic T cell (CD8+) mediated tumor cell destruction. The gene discussed is IL10; the disease is neoplasm.